WMSA
UROV

Weiss Multi-Strategy Advisers’s Urovant Sciences Ltd. UROV Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,335
Closed -$145K – 773
2019
Q3 		$145K Sell
15,335
-9,665
-39% -$83.8K ﹤0.01% 553
2019
Q2 		$198K Buy
25,000
+10,000
+67% +$82K 0.01% 469
2019
Q1 		$151K Hold
15,000
– – ﹤0.01% 483
2018
Q4 		$99K Buy
15,000
+4,146
+38% +$37.7K ﹤0.01% 427
2018
Q3 		$130K Buy
+10,854
New +$128K ﹤0.01% 496

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Weiss Multi-Strategy Advisers's UROV Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Urovant Sciences Ltd. (UROV) in Q4 2019, closing a stake of 15,335 shares — an estimated $145K sold.

Weiss Multi-Strategy Advisers first reported a position in UROV in Q3 2018 and held it in 5 quarters. The position peaked at $198K in Q2 2019. 25 funds tracked by Wall St. Rank hold UROV as of Q4 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Urovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 15,335 Urovant Sciences Ltd. shares in Q4 2019, an estimated $145K.
  • Weiss Multi-Strategy Advisers first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 5 quarters.
  • Weiss Multi-Strategy Advisers's Urovant Sciences Ltd. position peaked at $198K in Q2 2019.
  • 25 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.